Treating Negative Affect in Low Back Pain Patients
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Treating Negative Affect in Low Back Pain Patients is a clinical trial[1].
Key Facts
- Treating Negative Affect in Low Back Pain Patients is in the country of United States[2].
- Treating Negative Affect in Low Back Pain Patients's instance of is recorded as clinical trial[3].
- Treating Negative Affect in Low Back Pain Patients's start time is recorded as +2021-03-31T00:00:00Z[4].
- Treating Negative Affect in Low Back Pain Patients's end time is recorded as +2025-12-31T00:00:00Z[5].
- Treating Negative Affect in Low Back Pain Patients's main subject is recorded as pain[6].
- Treating Negative Affect in Low Back Pain Patients's number of participants is recorded as {'unit': '1', 'amount': '+300'}[7].
- Treating Negative Affect in Low Back Pain Patients's title is recorded as Proof of Concept Study to Treat Negative Affect in Chronic Low Back Pain[8].
- Treating Negative Affect in Low Back Pain Patients's short name is recorded as TNA-LBP[9].
- Treating Negative Affect in Low Back Pain Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Treating Negative Affect in Low Back Pain Patients's ClinicalTrials.gov ID is recorded as NCT04747314[11].
- Treating Negative Affect in Low Back Pain Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as serotonergic agent[13].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as duloxetine hydrochloride[14].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as aripiprazole[15].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as mirtazapine hydrochloride[16].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as citalopram hydrobromide[17].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as Bupropion[18].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as venlafaxine hydrochloride[19].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as sertraline[20].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as antidepressant[21].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as selective serotonin reuptake inhibitor[22].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as membrane transport modulator[23].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as Dopamine D2 Receptor Antagonists[24].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as serotonin–norepinephrine reuptake inhibitor[25].
- Treating Negative Affect in Low Back Pain Patients's research intervention is recorded as analgesic[26].